# A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Study · id `cardio:ct-nct02368314` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02368314](<https://clinicaltrials.gov/study/NCT02368314>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02368314

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

## Technical summary

Registry record NCT02368314. Randomized; triple masking; primary purpose prevention. Start 2015-01 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2016-10-24.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 124 participants (enrolled count; ClinicalTrials.gov record NCT02368314, source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)
- Start date: 2015-01 (registry gives no type) (ClinicalTrials.gov record NCT02368314, source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02368314, source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02368314, source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)
- Results first posted: 2016-10-24 (ClinicalTrials.gov record NCT02368314, source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)
- Countries: Russia (ClinicalTrials.gov record NCT02368314, source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02368314-2016-10-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries
- Condition: Deep Vein Thrombosis
- Intervention (Drug): Sodium Enoxaparine
- Lead sponsor: Biocad
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry lists this organization as the lead sponsor: Biocad (`cardio:org-biocad`)

## Provenance

Content hash: 9ab073f15b09f0e00fd6254b96b84b5f34d28335fc540ace8e4853f9e8fb0c6e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
